Navigation Links
Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
Date:12/1/2008

e to become or remain profitable; Vanda's inability to obtain the capital necessary to fund its research and development activities; Vanda's failure to identify or obtain rights to new product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products under its license and sublicense agreements and other factors that are described in the "Risk Factors" section (Part II, Item 1A) of Vanda's quarterly report on Form 10-Q for the quarter ended September 30, 2008 (File No. 000-51863). In addition to the risks described above and in Part II, Item 1A of Vanda's quarterly report on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

(1) Rajaratnam, Shantha M.W.; et al. "Melatonin agonist ta
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
2. S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis
3. Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology
4. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
5. Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma
6. CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
7. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
8. PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
9. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
10. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
11. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Minolta, Inc. (Konica Minolta) ( Tokyo : ... Ltda., an X-ray system equipment manufacturer based in Minas ... healthcare sales company, Konica Minolta Healthcare do ... market investment and growth With ... healthcare technical advancements and efficiencies are required. Aging and ...
(Date:7/2/2015)... ALPINION MEDICAL SYSTEMS Co., Ltd., announced today ... Developed to enhance user experience and patient care in ... produces superb image quality. With advanced imaging technologies, this ... imaging, and shared service applications. Confidence at ... E-CUBE Series, the E-CUBE 15 EX provides advanced women,s ...
(Date:7/2/2015)... July 2, 2015   Wilson Therapeutics AB , ... Hans Schikan to its board of directors. The appointment ... Meeting on June 30. "We are delighted ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans ... we look forward to his contributions to the Company." ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
(Date:7/2/2015)... , ... July 02, 2015 , ... ... software, announced today a new release of their flagship product, 3D Tooth Atlas, ... Human Dentition quiz section and new tutorial videos. This latest release of the ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... status of the Gelatin Capsule manufacturers. The report is a valuable source of ... report depicts the global and Chinese market for the Gelatin Capsule industry including ...
(Date:7/2/2015)... ... 02, 2015 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it has made two key appointments at its ... Manager at Catalent’s Schorndorf facility, which provides large scale, complex oral solid manufacturing ...
(Date:7/2/2015)... ... July 02, 2015 , ... Today, East Liverpool City Hospital announced ... at East Liverpool City Hospital (ELCH). Pam is currently the Chief Nursing Officer at ... of surgery. Pam holds a master’s degree in health care administration as well as ...
Breaking Medicine News(10 mins):Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3
... and loses 20 pounds by flooding his body with ... and blood to reach ultimate goal of sublime healthLOS ... CEO/Founder of iZO Cleanze, a comprehensive full-body detox program ... it of toxins, reaches the halfway point of his ...
... in Development of ,Next Generation, Dietary Supplements and Functional ... appointed Dr. Rudi E. Moerck as President & Chief ... CEO duties for Dr. Moerck comes on the heels ... Parry (India) Ltd, Chennai, India) announced last November. In ...
... Early research in animals suggests it might be possible ... appear to prevent noise-induced hearing loss in lab animals, ... finding suggests that it may be possible to create ... hearing loss in humans. , Two studies found that ...
... of Life is excited to announce that the David ... "Golfers drinking VaNu report feeling a higher ... an improved sense of well-being," said David Leadbetter, owner ... to VaNu during a PGA event in late 2008, ...
... 19 Varian Medical,Systems (NYSE: VAR ) today ... Therapy System, which is designed to help doctors to improve,treatments ... doctors,can use higher doses of radiation to control and manage ... , "CE mark is an important ...
... Dentistry - San Diego County,s premiere dental practice (online ... program designed to promote whole-body health at its newest ... Most people despise the dentist - the chemical smells, ... causes many Americans to skip the dentist altogether. But ...
Cached Medicine News:Health News:CEO of iZO Cleanze Completes Day 50 of 100-Day Juice Cleanse 2Health News:Valensa International's Dr. Rudi E. Moerck Appointed CEO 2Health News:A Pill to Prevent Hearing Loss? 2Health News:World-Renowned Golf Instructor David Leadbetter Promotes VaNu 2Health News:Varian Medical Systems Has Received CE Mark for Proton Therapy System 2Health News:Discover Whole Body Wellness Through a Revolutionary - and Natural - Approach to Dental Care 2Health News:Discover Whole Body Wellness Through a Revolutionary - and Natural - Approach to Dental Care 3
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
... Motorized tilt, user programmable memory two ... control on both chair sides, solid ... base. Single button folding armrests and ... handle on both chair sides, ergonomically ...
... A practical, comfortable chair for ... seat height is adjustable from ... by use of an independent ... rotatable through 360 and incorporates ...
Medicine Products: